. Animal studies of fine and ultrafine particulate matter, including experimental studies with concentrated ambient air samples, have found these exposures to be acutely toxic, supporting the epidemiologic association in humans (10) (11) (12) . Despite this strong evidence linking fine and ultrafine particle inhalation with adverse health effects, the mechanisms by which particle toxicity may be exerted are poorly understood. Indeed, the extent (Table 2) ranged from 261 to 6,435 min x mg/mi3. Subjects inhaled magnesium oxide fume with medical-grade air through a mouth-breathing face mask. All subjects completed an exposure in full without discomfort or difficulty. Subjects were asked to record their body temperature during the evening following the afternoon exposure and to document any symptoms including flulike symptoms of myalgias, fatigue, and rigors.
Pulmonary function testing. Baseline (preexposure) pulmonary function testing was performed in the early afternoon, and 18-hr (postexposure) pulmonary function testing was done the next morning. Pulmonary function testing was conducted with the subject in the sitting position. We measured forced expiratory volume in 1 sec (FEV1) using a rolling seal spirometer according to American Thoracic Society standards (22 Particle diameter cutoff (gm) Figure 1 . Diameters of furnace-generated magnesium oxide particles compared with those of zinc oxide particles. Particle size distribution was determined by micro-orifice uniform deposit impactor analysis. The total magnesium concentration during sampling was 90.6 mg/m3. The total zinc concentration was 6.3 mg/m3. See also Kuschner et al. (20) . (20) . The lower limits of detection of the kits (supplier's data) were as follows: TNF, 0.085 pg/ml; IL-1, 0.083 pg/ml; IL-6, 0.080 pg/ml; and IL-8, 3.0 pg/ml. Nondetectable observations were assigned a value one-half that of the lower detection limit in later statistical analyses. The cytokines analyzed were above the lower limit of detection in all BAL specimens except for TNF in three cases (one subject both postcontrol and postexposure and one additional subject postexposure only) and IL-8 in two subjects (both postexposure). We determined BAL supernatant total protein concentrations using a commercially available colorimetric assay (Bio-Rad Laboratories, Hercules, CA).
Statistical analyses. We used the SAS standard statistical package for data analysis Abbreviations: FEV1, forced expiratory volume in 1 sec; TLC, total lung capacity; DLCO, diffusing capacity for CO; SD, standard deviation.
Baseline spirometry was performed in the afternoon; 18-hr spirometry was performed the following morning. *p>0.20 for all differences.
(SAS Institute Inc., Cary, NC). We compared by matched paired t-test: baseline with postexposure spirometry; baseline with postexposure peripheral leukocyte counts; and control with postexposure BAL cell and supernatant cytokine concentrations.
Results
Symptoms, pulmonary function, and peripheral blood polymorphonuclear leukocyte concentrations. None of the subjects documented a fever or reported symptoms postexposure consistent with classic metal fume fever (myalgia, malaise, headache, or respiratory complaints). As shown in Table  3 , there was no overall postexposure fall in pulmonary function; slight increases in TLC (mean increase of 100 cc) and DLCO (mean increase of 0.9 ml/min/mm Hg) were not statistically significant. There was a mean decrease of peripheral blood polymorphonuclear leukocyte concentrations postexposure of 1.1 x 10-3 ± 1.0 x 10-3 (SE)/mm3 compared with baseline, which was also not statistically significant (p>0.3). Bronchoalveolar lavage cells and cytokines. Mean BAL constituent concentrations postexposure and control are shown in Table 4 . Overall, there were no statistically significant differences in concentrations of BAL neutrophils, macrophages, lymphocytes, or protein between postexposure studies and paired control values, nor any statistically significant postexposure increases in concentrations of any of the proinflammatory cytokines we studied (IL-1, IL-6, IL-8, and TNF).
Discussion
Inhalation of fine and ultrafine particulate magnesium oxide did not result in a symptomatic response or in any meaningful changes in lung function or in BAL concentrations of proinflammatory cells or cytokines at 20-hr follow-up. What might explain the lack of a pulmonary or systemic response following exposure to concentrations of particulates as high as 230 mg/mi3?
Although it is certainly possible that the particle exposure concentrations used in this investigation were simply too low to result in a detectable clinical response, this would be inconsistent with ambient air pollution data. Untoward health effects have been associated with short-term particulate exposure in concentrations several orders of magnitude below those to which subjects in this study were exposed, in the microgram per cubic meter range. (1-9,25) .
Particle size and dimension can be important determinants of toxicity, both because of delivered dose and through other morphologic mechanisms. It is possible that particles generated by our furnace system were different in size or shape from particles which, in other settings, have been linked with adverse health effects. In general, however, fine particles (diameters <2.5 pm) are thought to present the greatest health concern because they most easily enter the alveolar air space and because they may deliver more hits, or particles, per mass delivered. In our model, the vast majority of the furnace-generated particles were within respirable range and 98% were less than 1.8 pm. This would suggest that particle size and number per milligram, by themselves, do not provide a simple explanation for the lack of a response effect in our study. We cannot easily exclude potential effects of morphologic characteristics related to particle surface interactions.
It is possible that the follow-up time was either too early or too late to detect inflammatory changes in BAL. Our prior experience with zinc oxide, exposure to which is clearly proinflammatory, however, showed that 20 hr is an excellent time point to detect proinflammatory cytokine and cellular responses in the pulmonary microenvironment (18) (19) (20) . Moreover, this follow-up time point is appropriate in view of the known kinetics of the cytokines studied.
There were no significant methodological differences in this study compared with (26, 27) . These effects included a metal fume feverlike response in humans (maximum 580 mg/m3) (27) . Indeed, these are the only other controlled human exposures to magnesium oxide reported in the medical literature. In 1983, Hartmann et al. (28) reported that seven workers in a foundry developed fever following the introduction of a new founding technique that led to magnesium oxide fume exposure. Modification of the production system, with reduction of magnesium oxide fume generation, was associated with cessation of febrile episodes among workers.
However, no industrial hygiene data were provided to quantify exposure levels. In 1992, Takac (29) reported morphologic changes in the microstructure of organs, including lungs, of animals exposed to magnesite waste containing largely magnesium oxide. Rats and rabbits were used to biologically monitor the accumulation and effects of inhaling air contaminated by the magnesite industry in two locations in Czechoslovakia. Study animals were exposed to contaminated air for 6 months. Findings included alterations in ciliary length, the presence of Curshman's spirals in smears of pulmonary lavages, and minor goblet cell abnormalities. Again, however, no industrial hygiene data were provided to quantify exposure levels.
In summary, we found no evidence of any pulmonary inflammatory responses following short-term fine and ultrafine particle inhalation to high concentrations of magnesium oxide. Based on our previous experience with zinc oxide, we cannot explain this lack of response by insufficient exposure, insensitive measures of response, or small study size. This investigation suggests that the toxicology of metal oxide particles is not determined simply by particle size characteristics alone (i.e., the number of particles per milligram inhaled). Hypotheses of air pollution effects associated with inhalation of fine particles (<2.5 pm diameter) should heavily weigh chemical-specific mechanisms that may modify the dose response depending on the particle inhaled.
